Competing interests in multiple sclerosis research [6]

Lancet

Volumn 361, Issue 9354, 2003, Pages 350-351

  Noseworthy, John ^a   Kappos, Ludwig ^b   Daumer, Martin ^c  

^a MAYO CLINIC   (United States)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC DISEASE; DATA BASE; DRUG INDUSTRY; HUMAN; INTERNATIONAL COOPERATION; LABORATORY; LETTER; MEDICAL RESEARCH; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; STATISTICAL MODEL; VALIDATION PROCESS;

EID: 0037464726     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)12354-9     Document Type: Letter

References (5)

1. Weatherall D. Academia and industry: increasingly uneasy bedfellows. Lancet. 355:2000;1574.
2. Editorial. The tightening grip of big pharma. Lancet 2001; 357: 1141.
3. Davidoff F., DeAngelis C.D., Drazen J.M., et al. Sponsorship, authorship, and accountability. Lancet. 358:2001;854-856.
4. Editorial. Just how tainted has medicine become? Lancet 2002; 359: 1167.
5. Drazen J.M., Curfman G.D. Financial associations of authors. N Engl J Med. 346:2002;1901-1902.